Alert/Advisory
Alerts provide important advice about health products that may include safety information.
Latest alerts
-
Pharmacists may dispense alternative brands or strengths without a new prescription.
-
The oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be given to children under 6 years of age.
-
We have tested a further 6 imported, unregistered ivermectin products and found they are counterfeit under the Therapeutic Goods Act 1989.
Latest articles
-
Promethazine hydrochloride (Phenergan) not to be used in children under 6
Health professionals and consumers are advised that the oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be used in children under 6 years of age. -
Azithromycin and rare risk of cardiovascular death
An updated warning about the risk of sudden cardiovascular death has been added to the Product Information and Consumer Medicine Information documents for azithromycin. -
Updated warnings about persistent sexual dysfunction for antidepressants
The Product Information documents for antidepressants have been updated with warnings about sexual dysfunction continuing in some patients, after they stop using the medicines.
Latest publications
-
In consultation with the TGA, Edgewell has taken a precautionary approach and commenced a recall of all batches of these three products from the Australian market.
-
TGA Laboratories has released a report detailing testing of alkyl nitrite products